Cargando…
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study
BACKGROUND: Prostate-specific antigen (PSA) testing is limited in identifying prostate cancer (PCa) with modestly elevated PSA levels. Therefore, a robust method for the diagnosis of PCa is urgently needed. METHODS: A total of 203 men with a PSA level of ≥4 ng/ml were eligible for enrollment in this...
Autores principales: | Yang, Zhenrong, Bai, Hongsong, Hu, Linjun, Kong, Defeng, Li, Guoliang, Zhao, Changyun, Feng, Lin, Cheng, Shujun, Shou, Jianzhong, Zhang, Wen, Zhang, Kaitai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808177/ https://www.ncbi.nlm.nih.gov/pubmed/35128360 http://dx.doi.org/10.1016/j.eclinm.2021.101161 |
Ejemplares similares
-
Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis
por: Yang, Zhenrong, et al.
Publicado: (2022) -
Combination of CT and telomerase(+) circulating tumor cells improves diagnosis of small pulmonary nodules
por: Zhang, Wen, et al.
Publicado: (2021) -
Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma
por: Zhang, Wen, et al.
Publicado: (2021) -
Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis
por: Kong, Defeng, et al.
Publicado: (2021) -
Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
por: Kong, Defeng, et al.
Publicado: (2022)